PL366626A1 - Compositions and methods for the therapy and diagnosis of lung cancer - Google Patents

Compositions and methods for the therapy and diagnosis of lung cancer

Info

Publication number
PL366626A1
PL366626A1 PL01366626A PL36662601A PL366626A1 PL 366626 A1 PL366626 A1 PL 366626A1 PL 01366626 A PL01366626 A PL 01366626A PL 36662601 A PL36662601 A PL 36662601A PL 366626 A1 PL366626 A1 PL 366626A1
Authority
PL
Poland
Prior art keywords
diagnosis
therapy
compositions
methods
lung cancer
Prior art date
Application number
PL01366626A
Other languages
Polish (pl)
Inventor
Steven G. Reed
Michael J. Lodes
Raodoh Mohamath
Heather Secrist
Darin R. Benson
Carol Yoseph Indirias
Robert A. Henderson
Steven P. Fling
Paul A. Algate
Mark Elliot
Jane Mannion
Michael D. Kalos
Original Assignee
Corixa Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/738,973 external-priority patent/US20020110563A1/en
Application filed by Corixa Corporation filed Critical Corixa Corporation
Publication of PL366626A1 publication Critical patent/PL366626A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL01366626A 2000-03-29 2001-03-28 Compositions and methods for the therapy and diagnosis of lung cancer PL366626A1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US53803700A 2000-03-29 2000-03-29
US58893700A 2000-06-05 2000-06-05
US64087800A 2000-08-18 2000-08-18
US23451700P 2000-09-22 2000-09-22
US70451200A 2000-11-01 2000-11-01
US09/738,973 US20020110563A1 (en) 2000-11-01 2000-12-14 Compositions and methods for the therapy and diagnosis of lung cancer

Publications (1)

Publication Number Publication Date
PL366626A1 true PL366626A1 (en) 2005-02-07

Family

ID=27559252

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01366626A PL366626A1 (en) 2000-03-29 2001-03-28 Compositions and methods for the therapy and diagnosis of lung cancer

Country Status (7)

Country Link
JP (1) JP2004526401A (en)
AU (1) AU2001261007A1 (en)
CA (1) CA2404233A1 (en)
CZ (1) CZ20023567A3 (en)
HU (1) HUP0500345A2 (en)
PL (1) PL366626A1 (en)
WO (1) WO2001072295A2 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020082212A1 (en) * 2000-07-20 2002-06-27 Millennium Pharmaceuticals, Inc. 7716, a novel human ATPase and uses therefor
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
AU2002311909A1 (en) * 2001-05-11 2002-11-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20040081653A1 (en) 2002-08-16 2004-04-29 Raitano Arthur B. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
JP2006512923A (en) * 2002-10-18 2006-04-20 エルジー ライフサイエンス リミテッド Cancer-related gene family
DE10258051A1 (en) * 2002-12-11 2004-07-22 Metagen Pharmaceuticals Gmbh Use of substances that bind to HAT for the diagnosis and treatment of squamous cell carcinoma of the lungs
AU2003295189A1 (en) * 2002-12-17 2004-07-09 Fondazione Centro San Raffaele Del Monte Tabor Carcinoembryonic antigen-specific immunodominant epitope recognized by cd4+t cells and uses thereof
WO2004063221A1 (en) 2002-12-26 2004-07-29 Takeda Pharmaceutical Company Limited Metastin derivative and use thereof
WO2006001499A2 (en) 2004-06-25 2006-01-05 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
GB0512401D0 (en) * 2005-06-17 2005-07-27 Randox Lab Ltd Method
AR058584A1 (en) 2005-12-22 2008-02-13 Takeda Pharmaceutical METASTININE DERIVATIVES AND USE OF THE SAME
US8404643B2 (en) 2005-12-22 2013-03-26 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
JP2007263896A (en) * 2006-03-29 2007-10-11 Univ Nagoya Biomarker and method for predicting postoperative prognosis of lung cancer patients
JO3048B1 (en) 2006-10-25 2016-09-05 Takeda Pharmaceuticals Co Metastin Derivatives And Use Thereof
JP5648261B2 (en) * 2006-12-20 2015-01-07 東レ株式会社 Cancer detection method
MX337991B (en) 2008-08-05 2016-03-30 Toray Industries METHOD FOR DETECTING CANCER.
DK2322221T3 (en) 2008-08-05 2014-09-01 Toray Industries PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF CANCER
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
MX2011004176A (en) 2008-10-22 2011-09-21 Oncotherapy Science Inc Rab6kifl/kif20a epitope peptide and vaccines containing the same.
HUE040012T2 (en) 2010-02-04 2019-02-28 Toray Industries Pharmaceutical agent for treatment and/or prevention of cancer
KR101842893B1 (en) 2010-02-04 2018-03-28 도레이 카부시키가이샤 Pharmaceutical composition for treatment and/or prevention of cancer
BR112012018951C8 (en) 2010-02-04 2020-06-23 Toray Industries monoclonal antibody, pharmaceutical composition, pharmaceutical combination, use of an antibody, use of a pharmaceutical composition and use of a pharmaceutical combination
AU2011211699B2 (en) 2010-02-04 2015-01-22 Toray Industries, Inc. Pharmaceutical composition for treating and/or preventing cancer
JP5845899B2 (en) 2010-02-04 2016-01-20 東レ株式会社 Pharmaceutical composition for treatment and / or prevention of cancer
KR101871704B1 (en) 2010-02-04 2018-06-27 도레이 카부시키가이샤 Pharmaceutical composition for treatment and/or prevention of cancer
BR112014002619A2 (en) 2011-08-04 2018-10-09 Toray Industries, Inc pharmaceutical composition and method of treatment and / or prevention of pancreatic cancer and pharmaceutical combination
PT2740796T (en) 2011-08-04 2017-07-26 Toray Industries Pharmaceutical composition for treatment and/or prophylaxis of cancer
CN103764825B (en) 2011-08-04 2015-09-02 东丽株式会社 Cancer treat and/or prevent pharmaceutical composition
ES2629061T3 (en) 2011-08-04 2017-08-07 Toray Industries, Inc. Method for the detection of pancreatic cancer
KR101968499B1 (en) 2011-08-04 2019-04-12 도레이 카부시키가이샤 Cancer treatment and/or prevention drug composition
ES2672695T3 (en) 2011-08-04 2018-06-15 Toray Industries, Inc. Pharmaceutical composition for the treatment and / or prophylaxis of cancer
MX348579B (en) 2011-08-04 2017-06-20 Toray Industries Drug composition for cancer treatment and/or prevention.
ES2739380T3 (en) 2012-02-21 2020-01-30 Toray Industries Pharmaceutical composition for cancer treatment
MX357505B (en) 2012-02-21 2018-07-12 Toray Industries Medicinal composition for treating and/or preventing cancer.
AU2013223143B2 (en) 2012-02-21 2017-12-21 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of cancer
IN2014KN01714A (en) 2012-02-21 2015-10-23 Toray Industries
US9428581B2 (en) 2012-03-30 2016-08-30 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of gallbladder cancer
PT2832365T (en) 2012-03-30 2018-01-24 Toray Industries Pharmaceutical composition for treatment and/or prevention of liver cancer
CA2879185C (en) 2012-07-19 2021-08-24 Toray Industries, Inc. Method for detecting cancer
WO2014014082A1 (en) 2012-07-19 2014-01-23 東レ株式会社 Cancer detection method
CA2918989C (en) 2013-08-09 2021-11-02 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
CA2296792A1 (en) * 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
EP1187915A2 (en) * 1999-04-02 2002-03-20 Corixa Corporation Compounds for therapy and diagnosis of lung cancer and methods for their use
AU2001243142A1 (en) * 2000-02-03 2001-08-14 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2001079292A2 (en) * 2000-04-17 2001-10-25 Pharmacia & Upjohn Company Novel g protein-coupled receptors
EP1278844A2 (en) * 2000-05-03 2003-01-29 PHARMACIA & UPJOHN COMPANY G protein-coupled receptors
WO2001096390A2 (en) * 2000-06-09 2001-12-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer

Also Published As

Publication number Publication date
HUP0500345A2 (en) 2005-07-28
WO2001072295A3 (en) 2002-08-22
JP2004526401A (en) 2004-09-02
CZ20023567A3 (en) 2003-11-12
WO2001072295A2 (en) 2001-10-04
AU2001261007A1 (en) 2001-10-08
CA2404233A1 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
PL354093A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001261007A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
HUP0203968A3 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2002218770A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
HUP0600780A2 (en) Compositions and methods for the therapy and diagnosis of her-2/neu-associated malignancies
AU2001268259A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001249549A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2001269766A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
PL365244A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
HUP0200760A2 (en) Compounds and methods for therapy and diagnosis of lung cancer
AU2001265296A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2002311909A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU4185100A (en) Compounds for therapy and diagnosis of lung cancer and methods for their use
ZA200301204B (en) Compositions and methods for the diagnosis and treatment of tumor
AU2001280982A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002246519A8 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002303219A1 (en) Compositions and methods for the therapy and diagnosis of cancer
AU2002359330A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU8678501A (en) Compositions and methods for the diagnosis and treatment of tumor
AU2001259062A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002313726A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
EP1349485A4 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2001290518A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2003230849A8 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001273149A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)